Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Azelis Group (AZE.BR)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (€)	Price Target (€)	Rating
2022-03-30	22.60	-	No Rating
2022-12-20	25.66	21.50	Sell
2023-04-11	22.36	20.50	Sell
2023-08-08	20.04	19.50	Sell
2023-10-10	17.40	17.50	Sell
2023-11-13	18.59	16.50	Sell
2024-01-30	19.18	17.00	Sell
2024-03-15	19.24	18.50	Sell
2024-04-18	22.88	19.00	Sell
2024-05-31	19.44	20.00	Neutral
2024-08-08	17.20	18.50	Neutral
2024-10-21	18.56	19.00	Neutral
2025-01-17	19.59	22.00	Buy

Disclosures

UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.